COLL COLLEGIUM PHARMACEUTICAL INC Management Changes 8-K Filing 2025 - Board Expansion Collegium Pharmaceutical appointed Nancy Lurker as a new director, expanding the board from eight to nine members, effective February 4, 2025, with a cash retainer of $50,000 and restricted stock units valued at $412,500.Get access to all SEC 8-K filings of the COLLEGIUM PHARMACEUTICAL INC